AC Immune SA
ACIU
$2.20
$0.052.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.13% | 5.99% | 4.87% | 39.96% | 4.24% |
| Total Depreciation and Amortization | 6.41% | 0.59% | -0.42% | 0.50% | 1.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -82.84% | 58.74% | 2.68% | 109.05% | 162.32% |
| Change in Net Operating Assets | -96.05% | 1,731.75% | 799.81% | 8,291.51% | 3,753.75% |
| Cash from Operations | -201.75% | 204.92% | 207.63% | 170.58% | 173.66% |
| Capital Expenditure | -33.35% | 19.33% | 26.33% | 0.70% | -55.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 134.09% | -101,505.99% | -260.04% | -266.47% | -291.29% |
| Cash from Investing | 132.28% | -8,234.19% | -262.93% | -270.36% | -296.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -37.70% | -32.59% | -24.64% | -17.93% | -11.15% |
| Issuance of Common Stock | -99.99% | -99.69% | -99.69% | 1,469.90% | 1,934.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.81% | 94.20% | -- | -6,737.50% | -2,442.86% |
| Cash from Financing | -102.20% | -101.62% | -102.62% | 1,844.74% | 2,646.94% |
| Foreign Exchange rate Adjustments | -56.17% | -1,978.45% | -2.95% | -1,505.73% | -893.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -325.00% | -7,989.77% | -192.98% | 99.00% | 153.16% |